Should molecular subtype be recommended as one of the selection criteria for accelerated partial breast irradiation? Preliminary results from an Asian cohort.

Wadasadawala, Tabassum; Mondal, Monidipa; Paul, Siji Nojin; Parmar, Vani; Nair, Nita; Shet, Tanuja; Desai, Sangeeta; Gupta, Sudeep; Sarin, Rajiv

Wadasadawala, Tabassum; Mondal, Monidipa; Paul, Siji Nojin; Parmar, Vani; Nair, Nita; Shet, Tanuja; Desai, Sangeeta; Gupta, Sudeep; Sarin, Rajiv.

Afiliação

Wadasadawala T; Department of Radiation Oncology, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Tata Memorial Centre (TMC), Kharghar, Navi Mumbai.
Mondal M; Department of Radiation Oncology, Tata Memorial Hospital (TMH), Parel, Mumbai.
Paul SN; Department of Radiation Oncology (Medical Physics), ACTREC, TMC, Kharghar, Navi Mumbai.
Parmar V; Department of Surgical Oncology, ACTREC, TMC, Kharghar, Navi Mumbai.
Nair N; Department of Surgical Oncology, TMH, Parel, Mumbai.
Shet T; Department of Pathology, TMH, Parel, Mumbai.
Desai S; Department of Pathology, TMH, Parel, Mumbai.
Gupta S; Department of Medical Oncology, ACTREC,TMC, Kharghar, Navi Mumbai, India.
Sarin R; Department of Radiation Oncology, Tata Memorial Hospital (TMH), Parel, Mumbai.

J Contemp Brachytherapy ; 10(1): 47-57, 2018 Feb.

Article em En | MEDLINE | ID: mdl-29619056

Palavras-chave

accelerated partial breast irradiation; breast cancer; multicatheter interstitial brachytherapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Contemp Brachytherapy Ano de publicação: 2018 Tipo de documento: Article País de publicação: Polônia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google